These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17990317)

  • 21. Novel Method for Detection of PIK3CA Mutations in Circulating Tumor DNA of Patients with Colorectal Cancer.
    Pu W; Wang F; Li K; Xing C; Zhuang Z; Wang H; Bian H; Zhang R; Xiao L
    Appl Biochem Biotechnol; 2023 Dec; 195(12):7821-7831. PubMed ID: 37093531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival.
    Cochicho D; Esteves S; Rito M; Silva F; Martins L; Montalvão P; Cunha M; Magalhães M; Gil da Costa RM; Felix A
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand.
    Dechaphunkul A; Thongwatchara P; Thongsuksai P; Dechaphunkul T; Geater SL
    J Pathol Transl Med; 2022 May; 56(3):126-133. PubMed ID: 35209701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment.
    Portet S; Naoufal R; Tachon G; Simonneau A; Chalant A; Naar A; Milin S; Bataille B; Karayan-Tapon L
    Neurooncol Adv; 2019; 1(1):vdz003. PubMed ID: 32642646
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH
    Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis.
    Alqahtani A; Ayesh HSK; Halawani H
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31905960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological significance of ROCK1 and PIK3CA expression in nasopharyngeal carcinoma.
    Wang X; Huang Y; Guo R; Liu Y; Qian Y; Liu D; Dai X; Wei Z; Jin F; Liu Y
    Exp Ther Med; 2017 Mar; 13(3):1064-1068. PubMed ID: 28450943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinoma.
    Cai Y; Dodhia S; Su GH
    Oncotarget; 2017 Mar; 8(13):22203-22217. PubMed ID: 28108737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
    Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
    Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
    García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
    Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.
    Foy JP; Tortereau A; Caulin C; Le Texier V; Lavergne E; Thomas E; Chabaud S; Perol D; Lachuer J; Lang W; Hong WK; Goudot P; Lippman SM; Bertolus C; Saintigny P
    Oncotarget; 2016 Jun; 7(24):35932-35945. PubMed ID: 27027432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Aspects of Head and Neck Cancer Therapy.
    Puram SV; Rocco JW
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):971-92. PubMed ID: 26568543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.
    Giudice FS; Squarize CH
    J Carcinog Mutagen; 2013 Aug; Suppl 5():. PubMed ID: 25126449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIK3CA mutations in mucinous cystic neoplasms of the pancreas.
    Garcia-Carracedo D; Chen ZM; Qiu W; Huang AS; Tang SM; Hruban RH; Su GH
    Pancreas; 2014 Mar; 43(2):245-9. PubMed ID: 24518503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.
    Qiu W; Tong GX; Turk AT; Close LG; Caruana SM; Su GH
    Biomed Res Int; 2014; 2014():810487. PubMed ID: 24511546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.
    Chiosea SI; Grandis JR; Lui VW; Diergaarde B; Maxwell JH; Ferris RL; Kim SW; Luvison A; Miller M; Nikiforova MN
    BMC Cancer; 2013 Dec; 13():602. PubMed ID: 24341335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.
    Garcia-Carracedo D; Turk AT; Fine SA; Akhavan N; Tweel BC; Parsons R; Chabot JA; Allendorf JD; Genkinger JM; Remotti HE; Su GH
    Clin Cancer Res; 2013 Dec; 19(24):6830-41. PubMed ID: 24132918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.
    Schneck H; Blassl C; Meier-Stiegen F; Neves RP; Janni W; Fehm T; Neubauer H
    Mol Oncol; 2013 Oct; 7(5):976-86. PubMed ID: 23895914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.
    Chang KY; Tsai SY; Chen SH; Tsou HH; Yen CJ; Liu KJ; Fang HL; Wu HC; Chuang BF; Chou SW; Tang CK; Liu SY; Lu PJ; Yen CY; Chang JY
    J Biomed Sci; 2013 Jun; 20(1):43. PubMed ID: 23806066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular pathogenesis of head and neck squamous cell carcinoma.
    Rothenberg SM; Ellisen LW
    J Clin Invest; 2012 Jun; 122(6):1951-7. PubMed ID: 22833868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.